Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Kerr, Jasmine D ^a   Holden, Rachel M ^a   Morton, Alexander R ^a   Nolan, Robert L ^a   Hopman, Wilma M ^a   Pruss, Cynthia M ^a   Garland, Jocelyn S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Chronic kidney disease; Coronary artery calcification; Epicardial fat; Interleukin 6; Metabolic syndrome

Indexed keywords

ALBUMIN; CREATININE; FIBROBLAST GROWTH FACTOR 23; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6;

ABDOMINAL OBESITY; ADULT; ALBUMINURIA; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; EPICARDIAL FAT VOLUME; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ADIPOSITY; BIOLOGICAL MARKERS; CALCINOSIS; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ONTARIO; PERICARDIUM; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84872828094     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-26     Document Type: Article

References (40)

1. Metabolic syndrome and incident diabetes: current state of the evidence. Ford ES, Li C, Sattar N, Diabetes Care 2008 31 1898 1904 10.2337/dc08-0423 18591398
2. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Galassi A, Reynolds K, He J, Am J Med 2006 119 812 819 10.1016/j.amjmed.2006.02. 031 17000207 (Pubitemid 44415613)
3. The metabolic syndrome and chronic kidney disease in U.S. adults. Chen J, Muntner P, Hamm L, Jones DW, Batumen V, Fonseca V, Whelton PK, He J, Ann Intern Med 2004 140 167 174 14757614
4. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M, Am J Kidney Dis 2006 2006 48 383 391 (Pubitemid 44247252)
5. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K, J Clin Invest 2006 116 1784 1792 10.1172/JCI29126 16823476 (Pubitemid 44033298)
6. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G, Am J Physiol Endocrinol Metab 2001 280 745 E751 11287357
7. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes. Role of free fatty acids and tumor necrosis factor- Suganami T, Nishida I, Ogawa Y, Arterioscler Thromb Vasc Biol 2005 25 2062 2068 10.1161/01.ATV.0000183883.72263.13 16123319 (Pubitemid 41416301)
8. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Aljada A, Ghanim H, Assian E, Dandona P, Metabolism 2002 51 487 491 10.1053/meta.2002.31339 11912559 (Pubitemid 34406567)
9. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Iacobellis G, Corradi D, Sharma AM, Nat Clin Pract Cardiovasc Med 2005 2 536 543 10.1038/ncpcardio0319 16186852 (Pubitemid 41670345)
10. Human epicardial adipose tissue is a source of inflammatory mediators. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y, Circulation 2003 108 2460 2466 10.1161/01.CIR.0000099542.57313.C5 14581396 (Pubitemid 37444406)
11. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Yerramasu A, Dey D, Venuraju S, Anand DV, Atwal S, Corder R, Berman DS, Lahiri A, Atherosclerosis 2012 220 223 230 10.1016/j.atherosclerosis.2011.09.041 22015177
12. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Aydin H, Toprak A, Deyneli O, Yazici D, Tarcin O, Sancak S, Yavuz D, Alkalin S, Metabol Syndr Relat Dis 2010 8 229 234 10.1089/met.2009.0080
13. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients. Tonbul HZ, Kultigin T, Kayikcioglu H, Ozbek O, Kayrak M, Biyik Z, Ren Fail 2011 33 770 775 10.3109/0886022X.2011.599913 21770856
14. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis / calcification syndrome in ESRD patients. Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, Anil M, Tonbul HZ, Clin J Am Soc Nephrol 2011 6 8 1920 1925 10.2215/CJN.00890111 21757644
15. Association between chronic kidney disease and coronary artery calcification: the Dallas heart study. Kramer H, Toto R, Peshock R, Cooper R, Victor R, J Am Soc Nephrol 2005 16 2 507 513 10.1681/ASN.2004070610 15601745 (Pubitemid 41725148)
16. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Tomiyama C, Higa A, Dalboni MA, Cendoroglo M, Draibe SA, Cuppari L, Carvalho AB, Neto EM, Canziani ME, Nephrol Dial Transplant 2006 21 9 2464 2471 10.1093/ndt/gfl291 16735378 (Pubitemid 44644518)
17. Single-slice epicardial fat area measurement: do we need to measure the total epicardial fat volume? Oyama N, Goto D, Ito YM, Ishimori N, Mimura R, Furumoto T, Kato F, Tsutsui H, Tamaki N, Terae S, Shirato H, Jpn J Radiol 2011 29 104 109 10.1007/s11604-010-0524-z 21359935
18. Vitamins K and D status in stages 3-5 chronic kidney disease. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL, Clin J Am Soc Nephrol 2010 5 4 590 597 10.2215/CJN.06420909 20167683
19. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2011 39 1 S266
20. Canadian hypertension education program. The 2006 Canadian hypertension education program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Hemmelgarn BR, McAlister FA, Grover S, Myers MG, McKay DW, Bolli P, Abbott C, Schiffrin EL, Honos G, Burgess E, Mann K, Wilson T, Penner B, Tremblay G, Milot A, Chockalingam A, Touyz RM, Tobe SW, Can J Cardiol 2006 22 573 581 10.1016/S0828-282X(06)70279-3 16755312 (Pubitemid 44044213)
21. Canadian diabetes association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes 2003 27 suppl 2 7 S9
22. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
23. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 461 470 10075613 (Pubitemid 29135798)
24. Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendrikson S, Kusek JW, Van Lente F, Ann Intern Med 2006 145 247 254 16908915 (Pubitemid 46768608)
25. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R, Diabetes Care 2003 26 3320 3325 10.2337/diacare.26.12.3320 14633821 (Pubitemid 37466894)
26. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American heart association writing group. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K, Circulation 1996 94 1175 1192 10.1161/01.CIR.94.5.1175 8790070 (Pubitemid 26292883)
27. Quantification of coronary artery calcium using ultra fast computed tomography. Agatston AS, Janowitz WR, Hildner F, J Am Coll Cardiol 1990 15 827 832 10.1016/0735-1097(90)90282-T 2407762 (Pubitemid 20101575)
28. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
29. The association of pericardial fat with incident coronary heart disease: the multi-ethnic study of atherosclerosis (MESA). Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, Ouyang P, Espeland MA, Lohman KK, Criqui MH, Allison M, Bluemke DA, Carr JJ, Am J Clin Nutr 2009 90 499 504 10.3945/ajcn.2008.27358 19571212
30. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Karastergiou K, Evans I, Ogston N, Mibeisi N, Nair D, Kaski J, Jahangiri M, Mohamed-Ali V, Arterioscler Thromb Vasc Biol 2010 30 1340 1346 10.1161/ATVBAHA.110.204719 20395594
31. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Levin A, Djurdjev O, Beaulieu M, Er L, Am J Kidney Dis 2008 52 661 671 10.1053/j.ajkd.2008.06.023 18805347
32. Microalbuminuria- a biomarker of renal microvascular disease. Futrakul N, Sridama V, Futrakul P, Ren Fail 2009 31 140 143 10.1080/08860220802595948 19212911
33. Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. Tamba S, Nakatsuji H, Kishida K, Noguchi M, Ogawa T, Okauchi Y, Nishizawa H, Imagawa A, Nakamura T, Matsuzawa Y, Funahashi T, Shimomura I, Atherosclerosis 2010 211 601 605 10.1016/j.atherosclerosis.2010.02.037 20363472
34. Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Shibasaki I, Nishikimi T, Mochizuki Y, Yamada Y, Yoshitatsu M, Inoue Y, Kuwata T, Ogawa H, Tsuchiya G, Ishimitsu T, Fukuda H, Regul Pept 2010 165 210 217 10.1016/j.regpep.2010.07.169 20691218
35. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, Coresh J, Klein R, Kidney Int 2011 80 11 1231 1238 10.1038/ki.2011.283 21866089
36. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, Pickett W, Am J Kidney Dis 2008 2008 52 849 858
37. FGF-23: more than a regulator of renal phosphate handling? Jüppner H, Wolf M, Salusky IB, J Bone Miner Res 2010 25 2091 2097 10.1002/jbmr.170 20593414
38. Fibroblast growth factor-23 and early decrements in kidney function: the heart and soul study. Ix JH, Shlipak MG, Wassel CL, Whooley MA, Nephrol Dial Transplant 2010 25 993 997 10.1093/ndt/gfp699 20037168
39. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Balci M, Kirpantur A, Gulbay M, Gurbuz OA, Hemodial Int 2010 14 425 432 10.1111/j.1542-4758.2010.00480.x 20955275
40. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Mirza MAI, Alsio J, Hammarstedt A, Erben RG, Michaelsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellstrom D, Lind L, Ohlsson C, Larsson TE, Arterioscler Thromb Vasc Biol 2010 31 219 227 20966399